Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 205.55

-1.3%

Nov 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bryce Elkins who wrote (18702)	4/6/1998 4:23:00 PM
From: Henry Niman	Read Replies (1) of 32384

BLe, LGND's closing ask price was 15 7/16, which is close to the price you paid. I think it very briefly hit 15 5/16, but even when the bid fell to 15 1/8, the ask was usually at 15 3/8. The trading was heavily on the retail side, and I did get a chance to review the Inquirer story on Tamoxifen. It looks like about twice as many women develop blood clots on their lungs as the number that don't develop breast cancer and about 1/2 that number get endometrial cancer. Other's also develop uterine bleeding, so it's clear that there is considerable risk associated with the treatment. I'm not sure about the bleeding, but Targretin does help the endometrial problem in animal models. Joe Kernan just indicated that ZEN was up 10 today and even LLY got a boost because Evista works the same way as Tamoxifen (as does Droloxifene, CP-366,156, and TSE424, all of which involve LGND).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next